Bentires-Alj M - Search Results

1

Imagine beyond: recent breakthroughs and next challenges in mammary gland biology and breast cancer research.

van Amerongen R, Bentires-Alj M, van Boxtel AL, Clarke RB, Fre S, Suarez EG, Iggo R, Jechlinger M, Jonkers J, Mikkola ML, Koledova ZS, Sørlie T, Vivanco MD. van Amerongen R, et al. Among authors: bentires alj m. J Mammary Gland Biol Neoplasia. 2023 Jul 14;28(1):17. doi: 10.1007/s10911-023-09544-y. J Mammary Gland Biol Neoplasia. 2023. PMID: 37450065 Free PMC article. Review.

2

Selective blockade of NF-kappa B activity in airway immune cells inhibits the effector phase of experimental asthma.

Desmet C, Gosset P, Pajak B, Cataldo D, Bentires-Alj M, Lekeux P, Bureau F. Desmet C, et al. J Immunol. 2004 Nov 1;173(9):5766-75. doi: 10.4049/jimmunol.173.9.5766. J Immunol. 2004. PMID: 15494529

3

Mesenchymal precursor cells maintain the differentiation and proliferation potentials of breast epithelial cells.

Duss S, Brinkhaus H, Britschgi A, Cabuy E, Frey DM, Schaefer DJ, Bentires-Alj M. Duss S, et al. Breast Cancer Res. 2014 Jun 10;16(3):R60. doi: 10.1186/bcr3673. Breast Cancer Res. 2014. PMID: 24916766 Free PMC article.

4

Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium.

Meier-Abt F, Milani E, Roloff T, Brinkhaus H, Duss S, Meyer DS, Klebba I, Balwierz PJ, van Nimwegen E, Bentires-Alj M. Meier-Abt F, et al. Breast Cancer Res. 2013 Apr 29;15(2):R36. doi: 10.1186/bcr3419. Breast Cancer Res. 2013. PMID: 23621987 Free PMC article.

5

Co-expression of HER2 and HER3 receptor tyrosine kinases enhances invasion of breast cells via stimulation of interleukin-8 autocrine secretion.

Aceto N, Duss S, MacDonald G, Meyer DS, Roloff TC, Hynes NE, Bentires-Alj M. Aceto N, et al. Breast Cancer Res. 2012 Oct 12;14(5):R131. doi: 10.1186/bcr3329. Breast Cancer Res. 2012. PMID: 23062209 Free PMC article.

6

NF- kappa B2/p100 induces Bcl-2 expression.

Viatour P, Bentires-Alj M, Chariot A, Deregowski V, de Leval L, Merville MP, Bours V. Viatour P, et al. Leukemia. 2003 Jul;17(7):1349-56. doi: 10.1038/sj.leu.2402982. Leukemia. 2003. PMID: 12835724 Free article.

7

Stops along the RAS pathway in human genetic disease.

Bentires-Alj M, Kontaridis MI, Neel BG. Bentires-Alj M, et al. Nat Med. 2006 Mar;12(3):283-5. doi: 10.1038/nm0306-283. Nat Med. 2006. PMID: 16520774 No abstract available.

8

Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia.

Bentires-Alj M, Paez JG, David FS, Keilhack H, Halmos B, Naoki K, Maris JM, Richardson A, Bardelli A, Sugarbaker DJ, Richards WG, Du J, Girard L, Minna JD, Loh ML, Fisher DE, Velculescu VE, Vogelstein B, Meyerson M, Sellers WR, Neel BG. Bentires-Alj M, et al. Cancer Res. 2004 Dec 15;64(24):8816-20. doi: 10.1158/0008-5472.CAN-04-1923. Cancer Res. 2004. PMID: 15604238

9

A tumorigenic actin mutant alters fibroblast morphology and multicellular assembly properties.

Blache U, Silván U, Plodinec M, Suetterlin R, Jakob R, Klebba I, Bentires-Alj M, Aebi U, Schoenenberger CA. Blache U, et al. Cytoskeleton (Hoboken). 2013 Oct;70(10):635-50. doi: 10.1002/cm.21120. Epub 2013 Jul 19. Cytoskeleton (Hoboken). 2013. PMID: 23804571

10

Leukemic target susceptibility to natural killer cytotoxicity: relationship with BCR-ABL expression.

Baron F, Turhan AG, Giron-Michel J, Azzarone B, Bentires-Alj M, Bours V, Bourhis JH, Chouaib S, Caignard A. Baron F, et al. Blood. 2002 Mar 15;99(6):2107-13. doi: 10.1182/blood.v99.6.2107. Blood. 2002. PMID: 11877286 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

104 results

Search Page